|
Volumn 281, Issue 21, 1999, Pages 1978-
|
From the Food and Drug Administration.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIOBESITY AGENT;
LACTONE;
TETRAHYDROLIPSTATIN;
TRIACYLGLYCEROL LIPASE;
ARTICLE;
BLOOD TRANSFUSION;
DRUG ANTAGONISM;
DRUG APPROVAL;
EQUIPMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPOTENSION;
INSTRUMENTATION;
LEUKAPHERESIS;
POSTMARKETING SURVEILLANCE;
UNITED STATES;
ANTI-OBESITY AGENTS;
BLOOD TRANSFUSION;
DRUG APPROVAL;
EQUIPMENT FAILURE;
HUMANS;
HYPOTENSION;
LACTONES;
LEUKAPHERESIS;
LIPASE;
PRODUCT SURVEILLANCE, POSTMARKETING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
EID: 0033516190
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.281.21.1978-jfd90004-2-1 Document Type: Article |
Times cited : (7)
|
References (0)
|